GHK-Cu vs BPC-157
Both are repair-oriented peptides, but they target different tissue. GHK-Cu (a copper tripeptide) is best known for skin and cosmetic remodeling research, while BPC-157 is studied for deeper soft-tissue and gut repair.
| GHK-Cu (Copper Peptide) | BPC-157 | |
|---|---|---|
| Compound class | Copper tripeptide | Body-protection compound (pentadecapeptide) |
| Primary target | Tissue-remodeling & collagen signaling | Angiogenesis & tissue-repair pathways |
| Category | Healing & Recovery | Healing & Recovery |
| Administration | Subcutaneous or topical | Subcutaneous (local or systemic) |
| Research focus | Skin, hair & tissue remodeling | Soft-tissue, tendon & gut repair models |
Key differences
- Mechanism: GHK-Cu drives collagen and tissue-remodeling signaling via copper transport; BPC-157 drives angiogenesis and protective repair.
- Tissue focus: GHK-Cu is studied for skin, hair, and cosmetic endpoints; BPC-157 for tendon, muscle, and gut repair.
- Route: GHK-Cu can be used topically or subcutaneously; BPC-157 is typically injected.
- Use case: cosmetic/dermal research vs musculoskeletal and gastrointestinal research.
Which is right for your research?
Reach for GHK-Cu when the research is skin- and remodeling-focused, and BPC-157 when it is deeper soft-tissue or gut repair.
Frequently asked questions
Are GHK-Cu and BPC-157 used for the same thing?
Not quite. GHK-Cu is studied mainly for skin and cosmetic tissue remodeling, while BPC-157 is studied for deeper soft-tissue and gut repair.
Can GHK-Cu be applied topically?
GHK-Cu is researched both topically and subcutaneously, whereas BPC-157 is generally injected.
Do they share a mechanism?
Both relate to tissue repair, but GHK-Cu works through copper-mediated remodeling signaling and BPC-157 through angiogenesis and protective repair.
For Research Use Only. All products are sold as research chemicals for in-vitro laboratory study. Not for human consumption, medical, veterinary, or household use.